Neutrophil extracellular traps (NETs) are network-like structures of chromatin filaments decorated by histones, granules, and cytoplasmic-derived proteins expelled by activated neutrophils under multiple pathogenic conditions. NETs not only capture pathogens in innate immunity but also respond to sterile inflammatory stimuli in atherosclerosis, such as lipoproteins and inflammatory cytokines. Atherosclerosis is a lipid-driven chronic inflammatory disease characterized by the accumulation and transformation of inflammatory cells, and smooth muscle cells in the intimal space. NETs-derived extracellular components possess toxic and proinflammatory properties leading to cellular dysfunction and tissue damage, which may establish a link among lipid metabolism, inflammatory immunity, and atherosclerosis. In this review, we discuss recent advances regarding the role of NETs engaged in the pathogenesis of atherosclerosis, particularly focusing on the interaction with lipids and inflammasomes, crosstalk with smooth muscle cells and inflammatory cells, and the association with aging. We also evaluate the current knowledge on the potential of NETs as biomarkers and therapeutic targets for atherosclerosis and its related diseases in clinical practice.
TownsendNKazakiewiczDLucy WrightFTimmisAHuculeciRTorbicaAGaleCPAchenbachSWeidingerFVardasP. Epidemiology of cardiovascular disease in Europe.Nat Rev Cardiol2022;19:133–43
2.
MalekmohammadKBezsonovEERafieian-KopaeiM. Role of lipid accumulation and inflammation in atherosclerosis: focus on molecular and cellular mechanisms.Front Cardiovasc Med2021;8:707529
3.
LibbyP. Inflammation in atherosclerosis.Nature2002;420:868–74
4.
ThérouxPFusterV. Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction.Circulation1998;97:1195–206
5.
ThanviBRobinsonT. Complete occlusion of extracranial internal carotid artery: clinical features, pathophysiology, diagnosis and management.Postgrad Med J2007;83:95–9
LoodCBlancoLPPurmalekMMCarmona-RiveraCDe RavinSSSmithCKMalechHLLedbetterJAElkonKBKaplanMJ. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease.Nat Med2016;22:146–53
12.
PapayannopoulosVMetzlerKDHakkimAZychlinskyA. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps.J Cell Biol2010;191:677–91
13.
UrbanCFErmertDSchmidMAbu-AbedUGoosmannCNackenWBrinkmannVJungblutPRZychlinskyA. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans.PLoS Pathog2009;5:e1000639
14.
DwyerMShanQD’OrtonaSMaurerRMitchellROlesenHThielSHuebnerJGadjevaM. Cystic fibrosis sputum DNA has NETosis characteristics and neutrophil extracellular trap release is regulated by macrophage migration-inhibitory factor.J Innate Immun2014;6:765–79
15.
KlopfJBrostjanCEilenbergWNeumayerC. Neutrophil extracellular traps and their implications in cardiovascular and inflammatory disease.Int J Mol Sci2021;22:559
16.
TanCAzizMWangP. The vitals of NETs.J Leukoc Biol2021;110:797–808
17.
KennyEFHerzigAKrügerRMuthAMondalSThompsonPRBrinkmannVBernuthHVZychlinskyA. Diverse stimuli engage different neutrophil extracellular trap pathways.eLife2017;6:e24437
18.
FuchsTAAbedUGoosmannCHurwitzRSchulzeIWahnVWeinrauchYBrinkmannVZychlinskyA. Novel cell death program leads to neutrophil extracellular traps.J Cell Biol2007;176:231–41
19.
ChenTLiYSunRHuHLiuYHerrmannMZhaoYMuñozLE. Receptor-mediated NETosis on neutrophils.Front Immunol2021;12:775267
20.
VorobjevaNV. Neutrophil extracellular traps: new aspects.Moscow Univ Biol Sci Bull2020;75:173–88
LiuXArfmanTWichapongKReutelingspergerCPMVoorbergJNicolaesGAF. PAD4 takes charge during neutrophil activation: impact of PAD4 mediated NET formation on immune-mediated disease.J Thromb Haemost2021;19:1607–17
23.
Díaz-GodínezCFonsecaZNéquizMLacletteJPRosalesCCarreroJC. Entamoeba histolytica trophozoites induce a rapid non-classical NETosis mechanism independent of NOX2-derived reactive oxygen species and PAD4 activity.Front Cell Infect Microbiol2018;8:184
24.
ClaushuisTAMvan der DonkLEHLuitseALvan VeenHAvan der WelNNvan VughtLARoelofsJde BoerOJLankelmaJMBoonLde VosAFvan ’t VeerCvan der PollT. Role of peptidylarginine deiminase 4 in neutrophil extracellular trap formation and host defense during Klebsiella pneumoniae-induced pneumonia-derived sepsis.J Immunol2018;201:1241–52
25.
KayagakiNStoweIBLeeBLO’RourkeKAndersonKWarmingSCuellarTHaleyBRoose-GirmaMPhungQTLiuPSLillJRLiHWuJKummerfeldSZhangJLeeWPSnipasSJSalvesenGSMorrisLXFitzgeraldLZhangYBertramEMGoodnowCCDixitVM. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling.Nature2015;526:666–71
26.
SollbergerGChoidasABurnGLHabenbergerPDi LucreziaRKordesSMenningerSEickhoffJNussbaumerPKleblBKrügerRHerzigAZychlinskyA. Gasdermin D plays a vital role in the generation of neutrophil extracellular traps.Sci Immunol2018;3:eaar6689
27.
AmulicBKnackstedtSLAbu AbedUDeigendeschNHarbortCJCaffreyBEBrinkmannVHeppnerFLHindsPWZychlinskyA. Cell-cycle proteins control production of neutrophil extracellular traps.Dev Cell2017;43:449–625
28.
PilsczekFHSalinaDPoonKKFaheyCYippBGSibleyCDRobbinsSMGreenFHSuretteMGSugaiMBowdenMGHussainMZhangKKubesP. A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response toStaphylococcus aureus. J Immunol2010;185:7413–25
29.
AdroverJMAroca-CrevillénACrainiciucGOstosFRojas-VegaYRubio-PonceACillonizCBonzón-KulichenkoECalvoERicoDMoroMAWeberCLizasoaínITorresARuiz-CabelloJVázquezJHidalgoA. Programmed “disarming” of the neutrophil proteome reduces the magnitude of inflammation.Nat Immunol2020;21:135–44
30.
Dan DunnJAlvarezLAZhangXSoldatiT. Reactive oxygen species and mitochondria: a nexus of cellular homeostasis.Redox Biol2015;6:472–85
31.
YousefiSMihalacheCKozlowskiESchmidISimonHU. Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps.Cell Death Differ2009;16:1438–44
32.
WangHLiTChenSGuYYeS. Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin.Arthritis Rheumatol2015;67:3190–200
33.
LibbyP. The changing landscape of atherosclerosis.Nature2021;592:524–33
34.
MegensRTVijayanSLievensDDöringYvan ZandvoortMAGrommesJWeberCSoehnleinO. Presence of luminal neutrophil extracellular traps in atherosclerosis.Thromb Haemost2012;107:597–8
35.
Da SilvaRFBaptistaDRothAMitevaKBurgerFVuilleumierNCarboneFMontecuccoFMachFBrandtKJ. Anti-apolipoprotein A-1 IgG influences neutrophil extracellular trap content at distinct regions of human carotid plaques.Int J Mol Sci2020;21:7721
36.
RieggerJByrneRAJonerMChandraratneSGershlickAHTen BergJMAdriaenssensTGuagliumiGGodschalkTCNeumannFJTrenkDFeldmanLJStegPGDesmetWAlfonsoFGoodallAHWojdylaRDudekDPhilippiVOpinaldoSTitovaAMalikNCottonJJhagroeDAHeestermansAASinnaevePVermeerschPValinaCSchulzCKastratiAMassbergS. Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium.Eur Heart J2016;37:1538–49
37.
StarkKPhilippiVStockhausenSBusseJAntonelliAMillerMSchubertIHoseinpourPChandraratneSvon BrühlMLGaertnerFLorenzMAgrestiAColettiRAntoineDJHeermannRJungKReeseSLaitinenISchwaigerMWalchASperandioMNawrothPPReinhardtCJäckelSBianchiMEMassbergS. Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice.Blood2016;128:2435–49
38.
Patiño-TrivesAMPérez-SánchezCPérez-SánchezLLuque-TévarMÁbalos-AguileraMCAlcaide-RuggieroLArias-de la RosaIRomán-RodríguezCSeguíPEspinosaMFontPBarbarrojaNEscudero-ContrerasAAntonio González-ReyesJManuel VillalbaJCollantes-EstévezEAguirre-ZamoranoMÁLópez-PedreraC. Anti-dsDNA antibodies increase the cardiovascular risk in systemic lupus erythematosus promoting a distinctive immune and vascular activation.Arterioscler Thromb Vasc Biol2021;41:2417–30
39.
LibbyPRidkerPMHanssonGK. Progress and challenges in translating the biology of atherosclerosis.Nature2011;473:317–25
40.
AbelaGSAzizK. Cholesterol crystals cause mechanical damage to biological membranes: a proposed mechanism of plaque rupture and erosion leading to arterial thrombosis.Clin Cardiol2005;28:413–20
41.
NeumannABrogdenGJerjomicevaNBrodesserSNaimHYvon Köckritz-BlickwedeM. Lipid alterations in human blood-derived neutrophils lead to formation of neutrophil extracellular traps.Eur J Cell Biol2014;93:347–54
42.
HenneckTMerganiACleverSSeidlerAEBrogdenGRunftSBaumgärtnerWBranitzki-HeinemannKvon Köckritz-BlickwedeM. Formation of neutrophil extracellular traps by reduction of cellular cholesterol is independent of oxygen and HIF-1α.Int J Mol Sci2022;23:3195
43.
WarnatschAIoannouMWangQPapayannopoulos V. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis.Science2015;349:316–20
44.
AwasthiDNagarkotiSKumarADubeyMSinghAKPathakPChandraTBarthwalMKDikshitM. Oxidized LDL induced extracellular trap formation in human neutrophils via TLR-PKC-IRAK-MAPK and NADPH-oxidase activation.Free Radic Biol Med2016;93:190–203
HarithaVHGeorgeAShajiBVAnieY. NET-associated citrullinated histones promote LDL aggregation and foam cell formation in vitro.Exp Cell Res2020;396:112320
47.
RossRHarkerL. Hyperlipidemia and atherosclerosis.Science1976;193:1094–100
48.
DrechslerMMegensRTvan ZandvoortMWeberCSoehnleinO. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis.Circulation2010;122:1837–45
49.
LiuYCarmona-RiveraCMooreESetoNLKnightJSPryorMYangZHHemmersSRemaleyATMowenKAKaplanMJ. Myeloid-specific deletion of peptidylarginine deiminase 4 mitigates atherosclerosis.Front Immunol2018;9:1680
50.
JosefsTBarrettTJBrownEJQuezadaAWuXVoisinMAmengualJFisherEA. Neutrophil extracellular traps promote macrophage inflammation and impair atherosclerosis resolution in diabetic mice.JCI Insight2020;5:e134796
51.
KnightJSLuoWO’DellAAYalavarthiSZhaoWSubramanianVGuoCGrennRCThompsonPREitzmanDTKaplanMJ. Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis.Circ Res2014;114:947–56
52.
MolinaroRYuMSausenGBichselCACorboCFolcoEJLeeGYLiuYTesmenitskyYShvartzESukhovaGKKlossFCroceKJFarokhzadOCShiJLibbyP. Targeted delivery of protein arginine deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity.Cardiovasc Res2021;117:2652–63
53.
DhawanUKBhattacharyaPNarayananSManickamVAggarwalASubramanianM. Hypercholesterolemia impairs clearance of neutrophil extracellular traps and promotes inflammation and atherosclerotic plaque progression.Arterioscler Thromb Vasc Biol2021;41:2598–615
54.
GrebeAHossFLatzE. NLRP3 inflammasome and the IL-1 pathway in atherosclerosis.Circ Res2018;122:1722–40
55.
HoseiniZSepahvandFRashidiBSahebkarAMasoudifarAMirzaeiH. NLRP3 inflammasome: its regulation and involvement in atherosclerosis.J Cell Physiol2018;233:2116–32
56.
WolfDLeyK. Immunity and inflammation in atherosclerosis.Circ Res2019;124:315–27
57.
VanajaSKRathinamVAFitzgeraldKA. Mechanisms of inflammasome activation: recent advances and novel insights.Trends Cell Biol2015;25:308–15
58.
HuangYXuWZhouR. NLRP3 inflammasome activation and cell death.Cell Mol Immunol2021;18:2114–27
59.
RidkerPMEverettBMThurenTMacFadyenJGChangWHBallantyneCFonsecaFNicolauJKoenigWAnkerSDKasteleinJJPCornelJHPaisPPellaDGenestJCifkovaRLorenzattiAForsterTKobalavaZVida-SimitiLFlatherMShimokawaHOgawaHDellborgMRossiPRFTroquayRPTLibbyPGlynnRJ. Antiinflammatory therapy with canakinumab for atherosclerotic disease.N Engl J Med2017;377:1119–31
60.
Yvan-CharvetLWelchCPaglerTARanallettaMLamkanfiMHanSIshibashiMLiRWangNTallAR. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions.Circulation2008;118:1837–47
61.
TallARWesterterpM. Inflammasomes, neutrophil extracellular traps, and cholesterol.J Lipid Res2019;60:721–7
PagetCDoz-DeblauweEWinterNBriardB. Specific NLRP3 inflammasome assembling and regulation in neutrophils: relevance in inflammatory and infectious diseases.Cells2022;11:1188
LiHLiYSongCHuYDaiMLiuBPanP. Neutrophil extracellular traps augmented alveolar macrophage pyroptosis via AIM2 inflammasome activation in LPS-induced ALI/ARDS.J Inflamm Res2021;14:4839–58
66.
Jebari-BenslaimanSGalicia-GarcíaULarrea-SebalAOlaetxeaJRAllozaIVandenbroeckKBenito-VicenteAMartínC. Pathophysiology of atherosclerosis.Int J Mol Sci2022;23:3346
67.
ZhangXFernández-HernandoC. Transport of LDLs into the arterial wall: impact in atherosclerosis.Curr Opin Lipidol2020;31:279–85
68.
SouilholCSerbanovic-CanicJFragiadakiMChicoTJRidgerVRoddieHEvansPC. Endothelial responses to shear stress in atherosclerosis: a novel role for developmental genes.Nat Rev Cardiol2020;17:52–63
69.
ObamaTItabeH. Neutrophils as a novel target of modified low-density lipoproteins and an accelerator of cardiovascular diseases.Int J Mol Sci2020;21:8312
70.
GaoHWangXLinCAnZYuJCaoHFanYLiangX. Exosomal MALAT1 derived from ox-LDL-treated endothelial cells induce neutrophil extracellular traps to aggravate atherosclerosis.Biol Chem2020;401:367–76
71.
PieterseERotherNGarsenMHofstraJMSatchellSCHoffmannMLoevenMAKnaapenHKvan der HeijdenOWHBerdenJHMHilbrandsLBvan der VlagJ. Neutrophil extracellular traps drive endothelial-to-mesenchymal transition.Arterioscler Thromb Vasc Biol2017;37:1371–9
72.
WangLZhouXYinYMaiYWangDZhangX. Hyperglycemia induces neutrophil extracellular traps formation through an NADPH oxidase-dependent pathway in diabetic retinopathy.Front Immunol2018;9:3076
73.
HirotaTLevyJHIbaT. The influence of hyperglycemia on neutrophil extracellular trap formation and endothelial glycocalyx damage in a mouse model of type 2 diabetes.Microcirculation2020;27:e12617
74.
WangHWangQVenugopalJWangJKleimanKGuoCEitzmanDT. Obesity-induced endothelial dysfunction is prevented by neutrophil extracellular trap inhibition.Sci Rep2018;8:4881
75.
FahedACJangIK. Plaque erosion and acute coronary syndromes: phenotype, molecular characteristics and future directions.Nat Rev Cardiol2021;18:724–34
LinPJiHHLiYJGuoSD. Macrophage plasticity and atherosclerosis therapy.Front Mol Biosci2021;8:679797
78.
SchumskiAOrtega-GómezAWichapongKWinterCLemnitzerPViolaJRPinilla-VeraMFolcoESolis-MezarinoVVölker-AlbertMMaasSLPanCPerez OlivaresLWinterJHackengTKarlssonMCIZellerTImhofABaronRMNicolaesGAFLibbyPMaegdefesselLKampFBenoitMDöringYSoehnleinO. Endotoxinemia accelerates atherosclerosis through electrostatic charge-mediated monocyte adhesion.Circulation2021;143:254–66
79.
ConfortiAWahlersTPaunel-GörgülüA. Neutrophil extracellular traps modulate inflammatory markers and uptake of oxidized LDL by human and murine macrophages.PLoS ONE2021;16:e0259894
80.
ZhangYGSongYGuoXLMiaoRYFuYQMiaoCFZhangC. Exosomes derived from oxLDL-stimulated macrophages induce neutrophil extracellular traps to drive atherosclerosis.Cell Cycle2019;18:2674–84
81.
SanoMMaejimaYNakagamaSShiheido-WatanabeYTamuraNHiraoKIsobeMSasanoT. Neutrophil extracellular traps-mediated Beclin-1 suppression aggravates atherosclerosis by inhibiting macrophage autophagy.Front Cell Dev Biol2022;10:876147
PanHXueCAuerbachBJFanJBashoreACCuiJYangDYTrignanoSBLiuWShiJIhuegbuCOBushECWorleyJVlahosLLaisePSolomonRAConnollyESCalifanoASimsPAZhangHLiMReillyMP. Single-cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human.Circulation2020;142:2060–75
84.
AlencarGFOwsianyKMKarnewarSSukhavasiKMocciGNguyenATWilliamsCMShamsuzzamanSMokryMHendersonCAHaskinsRBaylisRAFinnAVMcNamaraCAZunderERVenkataVPasterkampGBjörkegrenJBekiranovSOwensGK. Stem cell pluripotency genes Klf4 and Oct4 regulate complex SMC phenotypic changes critical in late-stage atherosclerotic lesion pathogenesis.Circulation2020;142:2045–59
85.
DöringYLibbyPSoehnleinO. Neutrophil extracellular traps participate in cardiovascular diseases: recent experimental and clinical insights.Circ Res2020;126:1228–41
FangXMaLWangYRenFYuYYuanZWeiHZhangHSunY. Neutrophil extracellular traps accelerate vascular smooth muscle cell proliferation via Akt/CDKN1b/TK1 accompanying with the occurrence of hypertension.J Hypertens2022;40:2045–57
88.
Custodio-ChabléSJLezamaRAReyes-MaldonadoE. Platelet activation as a trigger factor for inflammation and atherosclerosis.Cir Cir2020;88:233–43
89.
WangLTangC. Targeting platelet in atherosclerosis plaque formation: current knowledge and future perspectives.Int J Mol Sci2020;21:9760
90.
Von HundelshausenPKoenenRRSackMMauseSFAdriaensWProudfootAEHackengTMWeberC. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium.Blood2005;105:924–30
91.
RossaintJHerterJMVan AkenHNapireiMDöringYWeberCSoehnleinOZarbockA. Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap-mediated sterile inflammation.Blood2014;123:2573–84
92.
KaiserREscaigRErberJNicolaiL. Neutrophil-platelet interactions as novel treatment targets in cardiovascular disease.Front Cardiovasc Med2021;8:824112
93.
PircherJCzermakTEhrlichAEberleCGaitzschEMargrafAGrommesJSahaPTitovaAIshikawa-AnkerholdHStarkKPetzoldTStockerTWeckbachLTNovotnyJSperandioMNieswandtBSmithAMannellHWalzogBHorstDSoehnleinOMassbergSSchulzC. Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammation.Nat Commun2018;9:1523
94.
MaugeriNCampanaLGavinaMCovinoCDe MetrioMPanciroliCMaiuriLMaseriAD’AngeloABianchiMERovere-QueriniPManfrediAA. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps.J Thromb Haemost2014;12:2074–88
95.
DhaneshaNNayakMKDoddapattarPJainMFloraGDKonSChauhanAK. Targeting myeloid-cell specific integrin α9β1 inhibits arterial thrombosis in mice.Blood2020;135:857–61
96.
SauterRJSauterMReisESEmschermannFNNordingHEbenhöchSKraftPMünzerPMaulerMRheinlaenderJMadlungJEdlichFSchäfferTEMeuthSGDuerschmiedDGeislerTBorstOGawazMKleinschnitzCLambrisJDLangerHF. Functional relevance of the anaphylatoxin receptor C3aR for platelet function and arterial thrombus formation marks an intersection point between innate immunity and thrombosis.Circulation2018;138:1720–35
97.
SchreiberARousselleABeckerJUvon MässenhausenALinkermannAKettritzR. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis.Proc Natl Acad Sci U S A2017;114:E9618–25
98.
HallyKEParkerOMBrunton-O’SullivanMMHardingSALarsenPD. Linking neutrophil extracellular traps and platelet activation: a composite biomarker score for predicting outcomes after acute myocardial infarction.Thromb Haemost2021;121:1637–49
99.
WangJCBennettM. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence.Circ Res2012;111:245–59
100.
BickAGWeinstockJSNandakumarSKFulcoCPBaoELZekavatSMSzetoMDLiaoXLeventhalMJNasserJChangKLaurieCBurugulaBBGibsonCJLinAETaubMAAguetFArdlieKMitchellBDBarnesKCMoscatiAFornageMRedlineSPsatyBMSilvermanEKWeissSTPalmerNDVasanRSBurchardEGKardiaSLRHeJKaplanRCSmithNLArnettDKSchwartzDACorreaAde AndradeMGuoXKonkleBACusterBPeraltaJMGuiHMeyersDAMcGarveySTChenIYShoemakerMBPeyserPABroomeJGGogartenSMWangFFWongQMontasserMEDayaMKennyEENorthKELaunerLJCadeBEBisJCChoMHLasky-SuJBowdenDWCupplesLAMakACYBeckerLCSmithJAKellyTNAslibekyanSHeckbertSRTiwariHKYangIVHeitJALubitzSAJohnsenJMCurranJEWenzelSEWeeksDERaoDCDarbarDMoonJYTracyRPButhEJRafaelsNLoosRJFDurdaPLiuYHouLLeeJKachrooPFreedmanBILevyDBielakLFHixsonJEFloydJSWhitselEAEllinorPTIrvinMRFingerlinTERaffieldLMArmasuSMWheelerMMSabinoECBlangeroJWilliamsLKLevyBDSheuWHRodenDMBoerwinkleEMansonJEMathiasRADesaiPTaylorKDJohnsonADAuerPLKooperbergCLaurieCCBlackwellTWSmithAVZhaoHLangeELangeLRichSSRotterJIWilsonJGScheetPKitzmanJOLanderESEngreitzJMEbertBLReinerAPJaiswalSAbecasisGSankaranVGKathiresanSNatarajanP. Inherited causes of clonal haematopoiesis in 97,691 whole genomes.Nature2020;586:763–8
101.
JaiswalSNatarajanPSilverAJGibsonCJBickAGShvartzEMcConkeyMGuptaNGabrielSArdissinoDBaberUMehranRFusterVDaneshJFrossardPSaleheenDMelanderOSukhovaGKNeubergDLibbyPKathiresanSEbertBL. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease.N Engl J Med2017;377:111–21
102.
WangWLiuWFidlerTWangYTangYWoodsBWelchCCaiBSilvestre-RoigCAiDYangYGHidalgoASoehnleinOTabasILevineRLTallARWangN. Macrophage inflammation, erythrophagocytosis, and accelerated atherosclerosis in Jak2V617F mice.Circ Res2018;123:e35–47
CovarrubiasAJPerroneRGrozioAVerdinE. NAD(+) metabolism and its roles in cellular processes during ageing.Nat Rev Mol Cell Biol2021;22:119–41
105.
WangYWangWWangNTallARTabasI. Mitochondrial oxidative stress promotes atherosclerosis and neutrophil extracellular traps in aged mice.Arterioscler Thromb Vasc Biol2017;37:e99–107
106.
ZhangDChenGManwaniDMorthaAXuCFaithJJBurkRDKunisakiYJangJEScheiermannCMeradMFrenettePS. Neutrophil ageing is regulated by the microbiome.Nature2015;525:528–32
LiberaleLMontecuccoFTardifJCLibbyPCamiciGG. Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease.Eur Heart J2020;41:2974–82
109.
BorissoffJIJoosenIAVersteylenMOBrillAFuchsTASavchenkoASGallantMMartinodKTen CateHHofstraLCrijnsHJWagnerDDKietselaerBLJH. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state.Arterioscler Thromb Vasc Biol2013;33:2032–40
110.
LangsethMSOpstadTBBratsethVSolheimSArnesenHPettersenAÅSeljeflotIHelsethR. Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease.Eur J Prev Cardiol2018;25:762–9
111.
LimHHJeongIHAnGDWooKSKimKHKimJMYunSHParkJIChaJKKimMHHanJY. Evaluation of neutrophil extracellular traps as the circulating marker for patients with acute coronary syndrome and acute ischemic stroke.J Clin Lab Anal2020;34:e23190
112.
HelsethRSheteligCAndersenGØLangsethMSLimalanathanSOpstadTBArnesenHHoffmannPEritslandJSeljeflotI. Neutrophil extracellular trap components associate with infarct size, ventricular function, and clinical outcome in STEMI.Mediators Inflamm2019;2019:7816491
113.
LangsethMSHelsethRRitschelVHansenCHAndersenGEritslandJHalvorsenSFagerlandMWSolheimSArnesenHSeljeflotIOpstadTB. Double-stranded DNA and NETs components in relation to clinical outcome after ST-elevation myocardial infarction.Sci Rep2020;10:5007
NovotnyJChandraratneSWeinbergerTPhilippiVStarkKEhrlichAPircherJKonradIOberdieckPTitovaAHotiQSchubertILegateKRUrtzNLorenzMPelisekJMassbergSvon BrühlMLSchulzC. Histological comparison of arterial thrombi in mice and men and the influence of Cl-amidine on thrombus formation.PLoS ONE2018;13:e0190728
116.
ZhangSGuoMLiuQLiuJCuiY. Neutrophil extracellular traps induce thrombogenicity in severe carotid stenosis.Immun Inflamm Dis2021;9:1025–36
117.
XuXWuYXuSYinYAgenoWDe StefanoVZhaoQQiX. Clinical significance of neutrophil extracellular traps biomarkers in thrombosis.Thromb J2022;20:63
118.
BangOYChungJWChoYHOhMJSeoWKKimGMAhnMJ. Circulating DNAs, a marker of neutrophil extracellular traposis and cancer-related stroke: the OASIS-cancer study.Stroke2019;50:2944–7
119.
ZuoYZuoMYalavarthiSGockmanKMadisonJAShiHWoodardWLezakSPLugogoNLKnightJSKanthiY. Neutrophil extracellular traps and thrombosis in COVID-19.J Thromb Thrombolysis2021;51:446–53
120.
NappiFBellomoFAvtaar SinghSS. Insights into the role of neutrophils and neutrophil extracellular traps in causing cardiovascular complications in patients with COVID-19: a systematic review.J Clin Med2022;11:2460
121.
FranckGMawsonTLFolcoEJMolinaroRRuvkunVEngelbertsenDLiuXTesmenitskyYShvartzESukhovaGKMichelJBNicolettiALichtmanAWagnerDCroceKJLibbyP. Roles of PAD4 and NETosis in experimental atherosclerosis and arterial injury: implications for superficial erosion.Circ Res2018;123:33–42
122.
LewisHDLiddleJCooteJEAtkinsonSJBarkerMDBaxBDBickerKLBinghamRPCampbellMChenYHChungCWCraggsPDDavisRPEberhardDJobertyGLindKELockeKMallerCMartinodKPattenCPolyakovaORiseCERüdigerMSheppardRJSladeDJThomasPThorpeJYaoGDrewesGWagnerDDThompsonPRPrinjhaRKWilsonDM. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.Nat Chem Biol2015;11:189–91
123.
DuMYangWSchmullSGuJXueS. Inhibition of peptidyl arginine deiminase-4 protects against myocardial infarction induced cardiac dysfunction.Int Immunopharmacol2020;78:106055
124.
DyerMRChenQHaldemanSYazdaniHHoffmanRLoughranPTsungAZuckerbraunBSSimmonsRLNealMD. Deep vein thrombosis in mice is regulated by platelet HMGB1 through release of neutrophil-extracellular traps and DNA.Sci Rep2018;8:2068
125.
ChiriviRGSvan RosmalenJWGvan der LindenMEulerMSchmetsGBogatkevichGKambasKHahnJBrasterQSoehnleinOHoffmannMHEsHHGVRaatsJMH. Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases.Cell Mol Immunol2021;18:1528–44
126.
VogelBShinagawaHHofmannUErtlGFrantzS. Acute DNase1 treatment improves left ventricular remodeling after myocardial infarction by disruption of free chromatin.Basic Res Cardiol2015;110:15
127.
GeLZhouXJiWJLuRYZhangYZhangYDMaYQZhaoJHLiYM. Neutrophil extracellular traps in ischemia-reperfusion injury-induced myocardial no-reflow: therapeutic potential of DNase-based reperfusion strategy.Am J Physiol Heart Circ Physiol2015;308:H500–9
128.
WangRZhuYLiuZChangLBaiXKangLCaoYYangXYuHShiMJHuYFanWZhaoBQ. Neutrophil extracellular traps promote tPA-induced brain hemorrhage via cGAS in mice with stroke.Blood2021;138:91–103
129.
SilvaCMSWanderleyCWSVerasFPSonegoFNascimentoDCGonçalvesAVMartinsTVCólonDFBorgesVFBrauerVSDamascenoLEASilvaKPToller-KawahisaJEBatahSSSouzaALJMonteiroVSOliveiraAERDonatePBZoppiDBorgesMCAlmeidaFNakayaHIFabroATCunhaTMAlves-FilhoJCZamboniDSCunhaFQ. Gasdermin D inhibition prevents multiple organ dysfunction during sepsis by blocking NET formation.Blood2021;138:2702–13
130.
SilvaCMSWanderleyCWSVerasFPGonçalvesAVLimaMHFToller-KawahisaJEGomesGFNascimentoDCMonteiroVVSPaivaIMAlmeidaCCaetitéDBSilvaJCLopesMIFBonjornoLPGianniniMCAmaralNBBenattiMNSantanaRCDamascenoLEASilvaBMSSchneiderAHCastroIMSSilvaJCSVasconcelosAPGonçalvesTTBatahSSRodriguesTSCostaVFPontelliMCMartinsRBMartinsTVEspósitoDLACebinelliGCMda FonsecaBALLeiriaLOSCunhaLDArrudaENakaiaHIFabroATOliveiraRDRZamboniDSLouzada-JuniorPCunhaTMAlves-FilhoJCFCunhaFQ. Gasdermin-D activation by SARS-CoV-2 triggers NET and mediate COVID-19 immunopathology.Crit Care2022;26:206
